274 related articles for article (PubMed ID: 20860833)
1. Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model.
Adedoyin MO; Vicini S; Neale JH
Mol Pain; 2010 Sep; 6():60. PubMed ID: 20860833
[TBL] [Abstract][Full Text] [Related]
2. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
Lea PM; Wroblewska B; Sarvey JM; Neale JH
J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
[TBL] [Abstract][Full Text] [Related]
3. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
[TBL] [Abstract][Full Text] [Related]
4. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
Yamamoto T; Kozikowski A; Zhou J; Neale JH
Mol Pain; 2008 Aug; 4():31. PubMed ID: 18673570
[TBL] [Abstract][Full Text] [Related]
6. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH
J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187
[TBL] [Abstract][Full Text] [Related]
7. NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation.
Yamada T; Zuo D; Yamamoto T; Olszewski RT; Bzdega T; Moffett JR; Neale JH
Mol Pain; 2012 Sep; 8():67. PubMed ID: 22971334
[TBL] [Abstract][Full Text] [Related]
8. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
[TBL] [Abstract][Full Text] [Related]
9. A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.
Nonaka T; Yamada T; Ishimura T; Zuo D; Moffett JR; Neale JH; Yamamoto T
Mol Pain; 2017 Jan; 13():1744806917697008. PubMed ID: 28326936
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
Olszewski RT; Wegorzewska MM; Monteiro AC; Krolikowski KA; Zhou J; Kozikowski AP; Long K; Mastropaolo J; Deutsch SI; Neale JH
Biol Psychiatry; 2008 Jan; 63(1):86-91. PubMed ID: 17597589
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
Yamamoto T; Hirasawa S; Wroblewska B; Grajkowska E; Zhou J; Kozikowski A; Wroblewski J; Neale JH
Eur J Neurosci; 2004 Jul; 20(2):483-94. PubMed ID: 15233757
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
Fricker AC; Mok MH; de la Flor R; Shah AJ; Woolley M; Dawson LA; Kew JN
Neuropharmacology; 2009; 56(6-7):1060-7. PubMed ID: 19285517
[TBL] [Abstract][Full Text] [Related]
13. Enhanced group II mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala.
Han JS; Fu Y; Bird GC; Neugebauer V
Mol Pain; 2006 May; 2():18. PubMed ID: 16681859
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.
Walder KK; Ryan SB; Bzdega T; Olszewski RT; Neale JH; Lindgren CA
Eur J Neurosci; 2013 Jan; 37(1):118-29. PubMed ID: 23134476
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.
Ren W; Palazzo E; Maione S; Neugebauer V
Neuropharmacology; 2011 Dec; 61(8):1334-44. PubMed ID: 21854791
[TBL] [Abstract][Full Text] [Related]
16. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
Li W; Neugebauer V
J Neurophysiol; 2006 Oct; 96(4):1803-15. PubMed ID: 16760343
[TBL] [Abstract][Full Text] [Related]
17. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
Profaci CP; Krolikowski KA; Olszewski RT; Neale JH
Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
[TBL] [Abstract][Full Text] [Related]
19. The regulatory role of NAAG-mGluR3 signaling on cortical synaptic plasticity after hypoxic ischemia.
Li K; Lu M; Cui M; Wang X; Zheng Y
Cell Commun Signal; 2022 Apr; 20(1):55. PubMed ID: 35443669
[TBL] [Abstract][Full Text] [Related]
20. Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.
Mazzitelli M; Neugebauer V
Neuropharmacology; 2019 Nov; 158():107706. PubMed ID: 31306647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
